TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $124,000 | +300.0% | 1,648 | +44.2% | 0.00% | – |
| Q1 2022 | $31,000 | +34.8% | 1,143 | +139.6% | 0.00% | – |
| Q4 2021 | $23,000 | +4.5% | 477 | +45.4% | 0.00% | – |
| Q3 2021 | $22,000 | -8.3% | 328 | +4.5% | 0.00% | – |
| Q2 2021 | $24,000 | +100.0% | 314 | +143.4% | 0.00% | – |
| Q1 2021 | $12,000 | -14.3% | 129 | +11.2% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 116 | -2.5% | 0.00% | – |
| Q3 2020 | $10,000 | +66.7% | 119 | +26.6% | 0.00% | – |
| Q2 2020 | $6,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |